Synthesis of 2-methylsulfanyl-1H-imidazoles as novel non-nucleoside reverse transcriptase inhibitors (NNRTIs)

Archiv der Pharmazie

Volumn 336, Issue 3, 2003, Pages 175-180

  Loksha, Yasser M ^a   El Badawi, Mahmoud A ^b   El Barbary, Ahmed A ^b   Pedersen, Erik B ^a   Nielsen, Claus ^c  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^b Tanta University   (Egypt)

^c STATENS SERUM INSTITUT   (Denmark)

Author keywords

Aminoketones; Human immunodeficiency virus; Imidazole 2 thiones; Non nucleoside reverse transcriptase inhibitors

Indexed keywords

2 METHYLSULFANYL 1H IMIDAZOLE; AMINOKETONE; CAPRAVIRINE; DELAVIRDINE; EFAVIRENZ; IMIDAZOLE DERIVATIVE; METHYL IODIDE; NEVIRAPINE; RNA DIRECTED DNA POLYMERASE INHIBITOR; THIOCYANATE POTASSIUM; UNCLASSIFIED DRUG;

ALKYLATION; ANTIVIRAL ACTIVITY; ARTICLE; COMPETITIVE INHIBITION; ENZYME INHIBITION; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYDROLYSIS; NONHUMAN; PRIORITY JOURNAL; REACTION ANALYSIS; STRAIN DIFFERENCE; SYNTHESIS; VASCULITIS;

CELL LINE; HIV-1; HUMANS; IMIDAZOLES; MAGNETIC RESONANCE SPECTROSCOPY; REVERSE TRANSCRIPTASE INHIBITORS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0037774803     PISSN: 03656233     EISSN: None     Source Type: Journal    
DOI: 10.1002/ardp.200390017     Document Type: Article

References (22)

1. R. Pauwels, K. Andries, J. Desmyter, D. Schols, M. J. Kukla, H. J. Breslin, A. Raeymaeckers, J. Van Gelder, R. Woestenborghs, J. Heykants, K. Schellenkens, M. A. C Janssen, E. De Clercq, P. A. J. Janssen, Nature 1990, 343, 470-474.
2. M. J. Kukla, H. J. Breslin, R. Pauwels, C. Fedde, M. Miranda, M. K Scott, R. G. Sherrill, A. Raeymaekers, J. Van Gelder, K. Andries, M. A. C. Janssen, E. De Clercq, P. A. J. Janssen, J. Med. Chem. 1991, 34, 746-751.
3. L. A. Kohlstaedt, J. Wang, J. M. Friedman, P. A. Rice, T. A. Steitz, Science 1992, 256, 1783-1790.
4. J. Ding, K. Das, H. Moereels, L. Koymans, K. Andries, P. A. J. Janssen, S. H. Hughes, E. Arnold, Nat. Struct. Biol. 1995, 2, 407-415.
5. P. P. Mager, Med. Res. Rev. 1997, 17, 235-276.
6. S. Swindells, Emerging Drugs 1997, 2, 155-173.
7. O. S. Pedersen, E. B. Pedersen, Antiviral Chem. Chemother. 1999, 10, 285-314.
8. E. De Clercq, Farmaco. 1999, 54, 26-45.
9. D. Richman, C. K. Shih, I. Lowy, J. Rose, P. Prodanovich, S. Goff, J. Griffin, Proc. Natl. Acad. Sci. U.S.A. 1991, 88, 11241-11245.
10. D. D. Richman, Annu. Rev. Pharmacol. Toxicol. 1993, 132, 149-164.
11. S. D. Young, S. F. Britcher, L. O. Tran, L. S. Payne, W. C. Lumma, T. A. Lyle, J. R. Huff, P. S. Anderson, D. B. Olsen, S. S. Carroll, D. J. Pettibone, J. A. O'Brien, R. G. Ball, S. K. Balani, J. H. Lin, I-W. Chen, W. A. Schleif, V. V. Sardana, W. J. Long, V. W. Byrnes, E. A. Emini, Antimicrob. Agents Chemother. 1995, 39, 2602-2605.
12. T. Fujiwara, A. Sato, M. El-Farrash, S. Miki, K. Abe, Y. Isaka, M. Kodama, Y. Wu, L. B. Chen, H. Harada, H. Sugimoto, M. Hatanaka, Y. Hinuma, Antimicrob. Agents Chemother. 1998, 42, 1340-1345.
13. Agouron Pharmaceuticals, Inc. Press release 25 Jan. 2002. http://www.agouron.com/Pages/press_releases/pr012501.html.
14. H. D. Dakin, R. West J. Biol. Chem. 1928, 78, 745-756.
15. H. D. Dakin, R. West J. Biol. Chem. 1928, 78, 757-764.
16. G. H. Cleland, C. Niemann J. Am. Chem. Soc. 1949, 71, 841-843.
17. Y. M. Loksha, P. T. Jrgensen, E. B. Pedersen, M. A. El-Badawi, A. A. El-Barbary, C. Nielsen, J. Heterocycl. Chem. 2002, 39, 375-382.
18. G. S. Sheppard, A. S. Florjancic, J. R. Giesler, L. Guo, Y. Xu, S. K. Davidsen, P. A. Marcotte, I. Elmore, D. H. Albert, T. J. Magoc, J. J. Bouska, C. L. Goodfellow, D. W. Morgan, J. B. Summers, Bioorg. Med. Chem. Lett. 1998, 8, 3251-3256.
19. R. A. F. Bullerwell, A. Lawson, J. Chem. Soc. 1952, 1350-1353.
20. M. Popovic, M. G. Sarngadharan, E. Read, R. C. Gallo Science 1984, 224, 497-500.
21. S. Harada, Y. Koyanagi, N. Yamamoto, Science 1985, 229, 563-566.
22. T. Mosmann, J. Immunol. Methods 1983, 63, 55-63.